Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Skechers USA Inc (SKX) Is a Bargain.. Buy It!

Page 1 of 2

Skechers USA Inc (NYSE:SKX), a brand best known for quality footwear for men, women, and children, has seen a stock turnaround since its launch into the performance footwear industry. Recently being named sports footwear brand of the year, and with a share-price increase of 442% from 2012, the company has recovered from the mistakes of years past and looks forward to the future with its performance division.

Skechers USA Inc (NYSE:SKX)

Product clean up

In 2011, Skechers USA Inc (NYSE:SKX) saw a declining share price and a dim future for its newly launched performance shoe line. Attempting to enter the sports-footwear category and expand its brand to fashion and sportswear, Skechers USA Inc (NYSE:SKX) launched a new toning shoe for the running industry. The company claimed that this shoe “increases muscle activity and energy consumption over standard fitness shoes.” However, with fitness studies proving otherwise, claims of false advertising let to a $50 million dollar settlement with the FTC, and losses from excess inventory exceeded $21.0 million.

Domestic competition

Although NIKE, Inc. (NYSE:NKE)has traditionally dominated the footwear industry, with Nike Flyknit catering specifically to the running community, Sketchers is launching rival products with its Skechers performance division. The company’s launch into performance running shoes has included the  GOWalk, GOrun, GOGolf, and Skechers USA Inc (NYSE:SKX) On-The-Go. These lines have performed well in retail stores and continue to grow in popularity within the running community.

NIKE, Inc. (NYSE:NKE)‘s revenue grew 9% to $6.2 billion for the last quarter as inventory increased by $3.3 billion. Nike saw revenue from the Nike brand rise 10% and its gross margin increase 30 basis points to 44.2%. Nike continues operational efficiency with cost-cutting measures and the shedding of unprofitable brands such as Umbro and Cole Haan. NIKE, Inc. (NYSE:NKE) continues to invest heavily in footwear lines such as NIKE, Jordan, Converse and Hurley, which will add growth in domestic markets as itsbrand popularity continues to grow.

The international market

With Asia-Pacific being at the forefront of the emerging middle class, footwear companies are scrambling to be at the front of this global emerging market. Currently around 150 million people are in the Chinese middle class with growth estimates of 1 billion by 2030. With the middle-class market in China becoming increasingly aware of the health benefits associated with exercise, this market is growing the most rapidly when it comes to footwear sales.

Due to higher disposable incomes, health awareness and trendy shoe designs, shoe makers Adidas (NASDAQOTH:ADDYY) and Nike are currently leading international markets hungry for athletic shoes. Currently, Adidas holds 11.2% of international market share, gaining ground on Nike, which currently holds 20% of all global footwear sales.

Adidas Group (which also includes Reebok, Rockport, and TaylorMade-Adidas Golf brands) reported a decline in sales of 2% to € 3.7 billion in the first quarter of 2013 from € 3.8 billion in 2012. Weakened demand for shoes, especially in other Asian markets, was the primary reason for declining revenue of 4% in the Japanese market.  Reebok continued the losses for the quarter largely due to a discontinued NFL contract and issues with products in Reebok India. Wholesale revenue for Adidas declined for the quarter by 3% due to a double-digit decline in Reebok sales.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!